Insulin Signaling and Metabolic Regulation in Adipocytes
Insulin Signaling and Metabolic Regulation in Adipocytes
批准号:
10194465
负责人:
MICHAEL P CZECH
金额:
$57.12万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-15 至 2023-06-30
关键词:
AddressAdipocytesAdipose tissueApolipoprotein EAtherosclerosisAttenuatedBeta CellBiologicalBlood GlucoseCardiovascular systemCell LineageCellsCore FacilityDataDepositionDiseaseEndothelial CellsEndotheliumEnergy MetabolismEngineeringEnzymesFatty AcidsFatty acid glycerol estersFinancial compensationFunctional disorderFundingFutureGene ExpressionGlucoseGrantHealthHomeostasisIn VitroInflammationInstructionInsulinInsulin ResistanceInsulin Signaling PathwayKRP proteinKnockout MiceLaboratoriesLipidsLiverLoxP-flanked alleleLymphaticMass Spectrum AnalysisMediatingMetabolicMetabolic ControlMetabolismMethodsMinkMolecularMusNon-Insulin-Dependent Diabetes MellitusObesityOperative Surgical ProceduresOrganOrthologous GeneParabiosisPathway interactionsPharmacotherapyPhenotypePlayProceduresProtein KinaseProteomicsRegulationResearchRoleSerumSignal PathwaySignal TransductionSignaling ProteinSkeletal MuscleSmall Interfering RNASubstrate SpecificityTechnologyTestingTissuesTriglyceridesWild Type MouseWorkadiponectincomorbiditydesignenhancing factorexperimental studyfatty acid metabolismglucose tolerancein vivoinsulin secretioninsulin sensitivityinsulin sensitizing drugsinsulin signalingisletlipid metabolismmetabolic phenotypemouse modelnew therapeutic targetresponsetranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This project, which has been funded for over 30 years, addresses fundamental mechanisms of insulin
action on adipose metabolism and functions that control whole body metabolic homeostasis in health and
disease. Co-morbidities associated with obesity including insulin resistance and type 2 diabetes are
thought to result from insufficient deposition and storage of triglyceride within adipose tissue, leading to
deleterious effects of fat on liver, skeletal muscle, cardiovascular organs and insulin secreting beta cells.
This project previously employed siRNA screens to discover the Ste20 ortholog Map4k4, a protein
kinase that acts as a critical signaling node in many tissues related to metabolic homeostasis. In
the previous grant period we have carefully assessed the role of Map4k4 in vivo showing that this protein
kinase functions in many tissues to suppress systemic insulin sensitivity as well as promote
atherosclerosis. Thus, we consistently observed beneficial metabolic phenotypes in six tissue-
specific Map4k4 knockout mouse models we produced, demonstrating that Map4k4 exerts powerful
biological effects worthy of continued study. Highlights of these studies include: 1. endothelial cell
Map4k4 KO lowers blood glucose and attenuates atherosclerosis in ApoE null mice, 2. Inducible whole
body Map4k4 KO mice show increased insulin sensitivity, much lower insulin levels and compromised
insulin secretion from islets, 3. Map4k4 KO in Myf5 positive cells (but not in Adiponectin positive cells)
causes a marked increase in adipocyte insulin sensitivity and Akt activation. This latter finding is consistent
with the exciting hypothesis that skeletal muscle secretes one or more factors that enhance insulin
sensitivity of adipocytes. Overall, our findings also suggest that two protein kinases very highly similar to
Map4k4, Tnik and Mink, may also be active in the same pathways. We have therefore produced triple
floxed Tnik/Mink/Map4k4 mice in order to test their potential redundancy with Map4k4 function in
adipocytes (lipid metabolism) by crossing with adiponectin-Cre mice and in beta cells (insulin
secretion) by crossing with Ins1Cre or Ins1CreER mice (Aim 1). We also propose to rigorously test the
exciting hypothesis that Map4k4 KO in Myf5 positive cells induces a circulating factor that enhances
adipocyte insulin sensitivity and glucose tolerance by parabiosis studies with the mouse models we have
engineered (Aim 2). Finally, in parallel we seek to identify such circulating factors in serum using
Somalogic technology and mass spectroscopy in the UMASS Proteomics Core Facility (Aim 3).
RELEVANCE (See instructions):
Fat tissue plays a key role in regulating energy metabolism, and excess accumulation of fat in obesity is
associated with many maladies including type 2 diabetes. We identified components of signaling pathways
in fat cells that mediate dysfunction in obesity and have studied an enzyme called Map4k4 that contributes
to insulin resistance, atherosclerosis and other diseases associated with metabolic functions. We hope to
further characterize Map4k4's functions, as it may be a good target for new drug therapies.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.molmet.2016.09.009
发表时间:
2016-12
期刊:
Molecular metabolism
影响因子:
8.1
作者:
[DiStefano MT, Roth Flach RJ, Senol-Cosar O, Danai LV, Virbasius JV, Nicoloro SM, Straubhaar J, Dagdeviren S, Wabitsch M, Gupta OT, Kim JK, Czech MP]
通讯作者:
Czech MP
DOI:
10.1038/ncomms10686
发表时间:
2016-02-16
期刊:
Nature communications
影响因子:
16.6
作者:
[Senol-Cosar O, Flach RJ, DiStefano M, Chawla A, Nicoloro S, Straubhaar J, Hardy OT, Noh HL, Kim JK, Wabitsch M, Scherer PE, Czech MP]
通讯作者:
Czech MP
DOI:
10.1016/j.tem.2016.04.006
发表时间:
2016-07
期刊:
Trends in endocrinology and metabolism: TEM
影响因子:
--
作者:
[Virbasius JV, Czech MP]
通讯作者:
Czech MP
CRISPR-enhanced adipocyte browning to improve glucose tolerance in obesity and diabetes
-
批准号:10335608
-
项目类别:
-
资助金额:$64.99万
-
财政年份:2021
-
负责人:MICHAEL P CZECH
-
依托单位:
CRISPR-enhanced adipocyte browning to improve glucose tolerance in obesity and diabetes
-
批准号:10649531
-
项目类别:
-
资助金额:$64.54万
-
财政年份:2021
-
负责人:MICHAEL P CZECH
-
依托单位:
CRISPR-enhanced adipocyte browning to improve glucose tolerance in obesity and diabetes
-
批准号:10490350
-
项目类别:
-
资助金额:$64.12万
-
财政年份:2021
-
负责人:MICHAEL P CZECH
-
依托单位:
Adipocyte to neuron signaling in thermogenic programming of white adipose tissue
-
批准号:10547782
-
项目类别:
-
资助金额:$58.29万
-
财政年份:2019
-
负责人:MICHAEL P CZECH
-
依托单位:
Adipocyte to neuron signaling in thermogenic programming of white adipose tissue
-
批准号:9889952
-
项目类别:
-
资助金额:$58.29万
-
财政年份:2019
-
负责人:MICHAEL P CZECH
-
依托单位:
Adipocyte to neuron signaling in thermogenic programming of white adipose tissue
-
批准号:10341100
-
项目类别:
-
资助金额:$58.29万
-
财政年份:2019
-
负责人:MICHAEL P CZECH
-
依托单位:
Adipocyte to neuron signaling in thermogenic programming of white adipose tissue
-
批准号:10087919
-
项目类别:
-
资助金额:$58.29万
-
财政年份:2019
-
负责人:MICHAEL P CZECH
-
依托单位:
Paracrine Signaling by Kupffer Cells in Hepatic Insulin Resistance
-
批准号:8888443
-
项目类别:
-
资助金额:$57.56万
-
财政年份:2015
-
负责人:MICHAEL P CZECH
-
依托单位:
Mechanisms of insulin resistance related to nonalcoholic steatohepatitis
-
批准号:10161771
-
项目类别:
-
资助金额:$66.91万
-
财政年份:2015
-
负责人:MICHAEL P CZECH
-
依托单位:
Mechanisms of insulin resistance related to nonalcoholic steatohepatitis
-
批准号:10371158
-
项目类别:
-
资助金额:$66.91万
-
财政年份:2015
-
负责人:MICHAEL P CZECH
-
依托单位:
Paracrine Signaling by Kupffer Cells in Hepatic Insulin Resistance
-
批准号:9029321
-
项目类别:
-
资助金额:$57.56万
-
财政年份:2015
-
负责人:MICHAEL P CZECH
-
依托单位:
Paracrine Signaling by Kupffer Cells in Hepatic Insulin Resistance
-
批准号:9240622
-
项目类别:
-
资助金额:$57.56万
-
财政年份:2015
-
负责人:MICHAEL P CZECH
-
依托单位:
Mechanisms of insulin resistance related to nonalcoholic steatohepatitis
-
批准号:10574534
-
项目类别:
-
资助金额:$66.91万
-
财政年份:2015
-
负责人:MICHAEL P CZECH
-
依托单位:
Oral Delivery Vehicles for RNAi Therapies
-
批准号:7763703
-
项目类别:
-
资助金额:$117.7万
-
财政年份:2009
-
负责人:MICHAEL P CZECH
-
依托单位:
Oral Delivery Vehicles for RNAi Therapies
-
批准号:8135990
-
项目类别:
-
资助金额:$118.64万
-
财政年份:2009
-
负责人:MICHAEL P CZECH
-
依托单位:
Insulin Signaling and Metabolic Regulation in Adipocytes
-
批准号:7996752
-
项目类别:
-
资助金额:$19.83万
-
财政年份:2009
-
负责人:MICHAEL P CZECH
-
依托单位:
Oral Delivery Vehicles for RNAi Therapies
-
批准号:8312634
-
项目类别:
-
资助金额:$118.64万
-
财政年份:2009
-
负责人:MICHAEL P CZECH
-
依托单位:
Oral Delivery Vehicles for RNAi Therapies
-
批准号:7935203
-
项目类别:
-
资助金额:$120.08万
-
财政年份:2009
-
负责人:MICHAEL P CZECH
-
依托单位:
SUBCELLULAR LOCALIZATION OF PI 3-KINASE SIGNALING
-
批准号:7299615
-
项目类别:
-
资助金额:$40.31万
-
财政年份:2007
-
负责人:MICHAEL P CZECH
-
依托单位:
Project 3: Molecular Mechanisms and Signaling Pathways for T Cell Anergy
-
批准号:7500384
-
项目类别:
-
资助金额:$14.72万
-
财政年份:2006
-
负责人:MICHAEL P CZECH
-
依托单位:
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位: